KINE-101D

N/A

Report date: 2022/05/10 11:44:24

NME

Base Information

Drug NameKINE-101D

Drug Alias NameKINE101D

ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs

Mechanisms of ActionRegulatory T-lymphocytes modulators

TargetsUpdating

Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

ATC CodeN/A